Selected research
Industry Research
KD Pharma (Marine Ingredients) Industry Research Report 2026
Market perspective
The global KD Pharma (Marine Ingredients) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for KD Pharma (Marine Ingredients) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for KD Pharma (Marine Ingredients) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for KD Pharma (Marine Ingredients) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of KD Pharma (Marine Ingredients) include Cargill, Bio-marine Ingredients Ireland, Sopropeche, Hofseth BioCare ASA, TripleNine Group, SA Copalis, Symrise, Scanbio and Bio-Oregon Protein, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global KD Pharma (Marine Ingredients) market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
KD Pharma (Marine Ingredients) Market by Company
Cargill
Bio-marine Ingredients Ireland
Sopropeche
Hofseth BioCare ASA
TripleNine Group
SA Copalis
Symrise
Scanbio
Bio-Oregon Protein
A. Costantino & C. S.P.A.
Alaska Protein Recovery
Gelita AG
Jiangxi Cosen Biochemical
Titan Biotech
KD Pharma (Marine Ingredients) Segment by Type
Protein
Ash
Fatty Acids
Others
KD Pharma (Marine Ingredients) Segment by Application
Poultry Feed
Aquaculture
Cosmetics & Personal Care
Other
KD Pharma (Marine Ingredients) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global KD Pharma (Marine Ingredients) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of KD Pharma (Marine Ingredients) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of KD Pharma (Marine Ingredients).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of KD Pharma (Marine Ingredients) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of KD Pharma (Marine Ingredients) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of KD Pharma (Marine Ingredients) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Protein
- Ash
- Fatty Acids
- Others
Applications
- Poultry Feed
- Aquaculture
- Cosmetics & Personal Care
- Other
Companies covered
- Cargill
- Bio-marine Ingredients Ireland
- Sopropeche
- Hofseth BioCare ASA
- TripleNine Group
- SA Copalis
- Symrise
- Scanbio
- Bio-Oregon Protein
- A. Costantino & C. S.P.A.
- Alaska Protein Recovery
- Gelita AG
- Jiangxi Cosen Biochemical
- Titan Biotech
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global KD Pharma (Marine Ingredients) Market Size (2021-2032)
- 2.2.2 Global KD Pharma (Marine Ingredients) Sales (2021-2032)
- 2.2.3 Global KD Pharma (Marine Ingredients) Market Average Price (2021-2032)
- 2.3 KD Pharma (Marine Ingredients) by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Protein
- 2.3.3 Ash
- 2.3.4 Fatty Acids
- 2.3.5 Others
- 2.4 KD Pharma (Marine Ingredients) by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Poultry Feed
- 2.4.3 Aquaculture
- 2.4.4 Cosmetics & Personal Care
- 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global KD Pharma (Marine Ingredients) Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global KD Pharma (Marine Ingredients) Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global KD Pharma (Marine Ingredients) Revenue of Manufacturers (2021-2026)
- 3.4 Global KD Pharma (Marine Ingredients) Average Price by Manufacturers (2021-2026)
- 3.5 Global KD Pharma (Marine Ingredients) Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of KD Pharma (Marine Ingredients), Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of KD Pharma (Marine Ingredients), Product Type & Application
- 3.8 Global Manufacturers of KD Pharma (Marine Ingredients), Established Date
- 3.9 Global KD Pharma (Marine Ingredients) Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Cargill
- 4.1.1 Cargill Company Information
- 4.1.2 Cargill Business Overview
- 4.1.3 Cargill KD Pharma (Marine Ingredients) Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Cargill KD Pharma (Marine Ingredients) Product Portfolio
- 4.1.5 Cargill Recent Developments
- 4.2 Bio-marine Ingredients Ireland
- 4.2.1 Bio-marine Ingredients Ireland Company Information
- 4.2.2 Bio-marine Ingredients Ireland Business Overview
- 4.2.3 Bio-marine Ingredients Ireland KD Pharma (Marine Ingredients) Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Bio-marine Ingredients Ireland KD Pharma (Marine Ingredients) Product Portfolio
- 4.2.5 Bio-marine Ingredients Ireland Recent Developments
- 4.3 Sopropeche
- 4.3.1 Sopropeche Company Information
- 4.3.2 Sopropeche Business Overview
- 4.3.3 Sopropeche KD Pharma (Marine Ingredients) Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sopropeche KD Pharma (Marine Ingredients) Product Portfolio
- 4.3.5 Sopropeche Recent Developments
- 4.4 Hofseth BioCare ASA
- 4.4.1 Hofseth BioCare ASA Company Information
- 4.4.2 Hofseth BioCare ASA Business Overview
- 4.4.3 Hofseth BioCare ASA KD Pharma (Marine Ingredients) Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Hofseth BioCare ASA KD Pharma (Marine Ingredients) Product Portfolio
- 4.4.5 Hofseth BioCare ASA Recent Developments
- 4.5 TripleNine Group
- 4.5.1 TripleNine Group Company Information
- 4.5.2 TripleNine Group Business Overview
- 4.5.3 TripleNine Group KD Pharma (Marine Ingredients) Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 TripleNine Group KD Pharma (Marine Ingredients) Product Portfolio
- 4.5.5 TripleNine Group Recent Developments
- 4.6 SA Copalis
- 4.6.1 SA Copalis Company Information
- 4.6.2 SA Copalis Business Overview
- 4.6.3 SA Copalis KD Pharma (Marine Ingredients) Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 SA Copalis KD Pharma (Marine Ingredients) Product Portfolio
- 4.6.5 SA Copalis Recent Developments
- 4.7 Symrise
- 4.7.1 Symrise Company Information
- 4.7.2 Symrise Business Overview
- 4.7.3 Symrise KD Pharma (Marine Ingredients) Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Symrise KD Pharma (Marine Ingredients) Product Portfolio
- 4.7.5 Symrise Recent Developments
- 4.8 Scanbio
- 4.8.1 Scanbio Company Information
- 4.8.2 Scanbio Business Overview
- 4.8.3 Scanbio KD Pharma (Marine Ingredients) Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Scanbio KD Pharma (Marine Ingredients) Product Portfolio
- 4.8.5 Scanbio Recent Developments
- 4.9 Bio-Oregon Protein
- 4.9.1 Bio-Oregon Protein Company Information
- 4.9.2 Bio-Oregon Protein Business Overview
- 4.9.3 Bio-Oregon Protein KD Pharma (Marine Ingredients) Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Bio-Oregon Protein KD Pharma (Marine Ingredients) Product Portfolio
- 4.9.5 Bio-Oregon Protein Recent Developments
- 4.10 A. Costantino & C. S.P.A.
- 4.10.1 A. Costantino & C. S.P.A. Company Information
- 4.10.2 A. Costantino & C. S.P.A. Business Overview
- 4.10.3 A. Costantino & C. S.P.A. KD Pharma (Marine Ingredients) Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 A. Costantino & C. S.P.A. KD Pharma (Marine Ingredients) Product Portfolio
- 4.10.5 A. Costantino & C. S.P.A. Recent Developments
- 4.11 Alaska Protein Recovery
- 4.11.1 Alaska Protein Recovery Company Information
- 4.11.2 Alaska Protein Recovery Business Overview
- 4.11.3 Alaska Protein Recovery KD Pharma (Marine Ingredients) Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Alaska Protein Recovery KD Pharma (Marine Ingredients) Product Portfolio
- 4.11.5 Alaska Protein Recovery Recent Developments
- 4.12 Gelita AG
- 4.12.1 Gelita AG Company Information
- 4.12.2 Gelita AG Business Overview
- 4.12.3 Gelita AG KD Pharma (Marine Ingredients) Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Gelita AG KD Pharma (Marine Ingredients) Product Portfolio
- 4.12.5 Gelita AG Recent Developments
- 4.13 Jiangxi Cosen Biochemical
- 4.13.1 Jiangxi Cosen Biochemical Company Information
- 4.13.2 Jiangxi Cosen Biochemical Business Overview
- 4.13.3 Jiangxi Cosen Biochemical KD Pharma (Marine Ingredients) Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Jiangxi Cosen Biochemical KD Pharma (Marine Ingredients) Product Portfolio
- 4.13.5 Jiangxi Cosen Biochemical Recent Developments
- 4.14 Titan Biotech
- 4.14.1 Titan Biotech Company Information
- 4.14.2 Titan Biotech Business Overview
- 4.14.3 Titan Biotech KD Pharma (Marine Ingredients) Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Titan Biotech KD Pharma (Marine Ingredients) Product Portfolio
- 4.14.5 Titan Biotech Recent Developments
5 Global KD Pharma (Marine Ingredients) Market Scenario by Region
- 5.1 Global KD Pharma (Marine Ingredients) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global KD Pharma (Marine Ingredients) Sales by Region: 2021-2032
- 5.2.1 Global KD Pharma (Marine Ingredients) Sales by Region: 2021-2026
- 5.2.2 Global KD Pharma (Marine Ingredients) Sales by Region: 2027-2032
- 5.3 Global KD Pharma (Marine Ingredients) Revenue by Region: 2021-2032
- 5.3.1 Global KD Pharma (Marine Ingredients) Revenue by Region: 2021-2026
- 5.3.2 Global KD Pharma (Marine Ingredients) Revenue by Region: 2027-2032
- 5.4 North America KD Pharma (Marine Ingredients) Market Facts & Figures by Country
- 5.4.1 North America KD Pharma (Marine Ingredients) Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America KD Pharma (Marine Ingredients) Sales by Country (2021-2032)
- 5.4.3 North America KD Pharma (Marine Ingredients) Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe KD Pharma (Marine Ingredients) Market Facts & Figures by Country
- 5.5.1 Europe KD Pharma (Marine Ingredients) Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe KD Pharma (Marine Ingredients) Sales by Country (2021-2032)
- 5.5.3 Europe KD Pharma (Marine Ingredients) Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific KD Pharma (Marine Ingredients) Market Facts & Figures by Country
- 5.6.1 Asia Pacific KD Pharma (Marine Ingredients) Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific KD Pharma (Marine Ingredients) Sales by Country (2021-2032)
- 5.6.3 Asia Pacific KD Pharma (Marine Ingredients) Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America KD Pharma (Marine Ingredients) Market Facts & Figures by Country
- 5.7.1 South America KD Pharma (Marine Ingredients) Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America KD Pharma (Marine Ingredients) Sales by Country (2021-2032)
- 5.7.3 South America KD Pharma (Marine Ingredients) Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa KD Pharma (Marine Ingredients) Market Facts & Figures by Country
- 5.8.1 Middle East and Africa KD Pharma (Marine Ingredients) Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa KD Pharma (Marine Ingredients) Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa KD Pharma (Marine Ingredients) Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global KD Pharma (Marine Ingredients) Sales by Type (2021-2032)
- 6.1.1 Global KD Pharma (Marine Ingredients) Sales by Type (2021-2032) & (k units)
- 6.1.2 Global KD Pharma (Marine Ingredients) Sales Market Share by Type (2021-2032)
- 6.2 Global KD Pharma (Marine Ingredients) Revenue by Type (2021-2032)
- 6.2.1 Global KD Pharma (Marine Ingredients) Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global KD Pharma (Marine Ingredients) Revenue Market Share by Type (2021-2032)
- 6.3 Global KD Pharma (Marine Ingredients) Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global KD Pharma (Marine Ingredients) Sales by Application (2021-2032)
- 7.1.1 Global KD Pharma (Marine Ingredients) Sales by Application (2021-2032) & (k units)
- 7.1.2 Global KD Pharma (Marine Ingredients) Sales Market Share by Application (2021-2032)
- 7.2 Global KD Pharma (Marine Ingredients) Revenue by Application (2021-2032)
- 7.2.1 Global KD Pharma (Marine Ingredients) Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global KD Pharma (Marine Ingredients) Revenue Market Share by Application (2021-2032)
- 7.3 Global KD Pharma (Marine Ingredients) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 KD Pharma (Marine Ingredients) Value Chain Analysis
- 8.1.1 KD Pharma (Marine Ingredients) Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 KD Pharma (Marine Ingredients) Production Mode & Process
- 8.2 KD Pharma (Marine Ingredients) Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 KD Pharma (Marine Ingredients) Distributors
- 8.2.3 KD Pharma (Marine Ingredients) Customers
9 Global KD Pharma (Marine Ingredients) Analyzing Market Dynamics
- 9.1 KD Pharma (Marine Ingredients) Industry Trends
- 9.2 KD Pharma (Marine Ingredients) Industry Drivers
- 9.3 KD Pharma (Marine Ingredients) Industry Opportunities and Challenges
- 9.4 KD Pharma (Marine Ingredients) Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst